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Abstract Skp1 interacts with cullins, F-box containing pro-
teins, and forms a complex with cyclin A-Cdk2 in mammalian
cells. Skp1 is also involved in diverse biological processes like
degradation of key cell cycle regulators, glucose sensing, and
kinetochore function. However, little is known about the
structure and exact function of Skp1. Here we characterized
the interaction between Skp1 and the F-box protein Skp2. We
show that Skp1 can bind to Skp2 in vitro using recombinant
proteins, and in vivo using the yeast two-hybrid system. Deletion
analysis of Skp1 indicated that most of the Skp1 protein is
required for binding to Skp2. In mammalian cell extracts, a large
portion of Skp1 appears to associate with proteins other than
Skp2. Biochemical analysis indicated that Skp1 is likely to be a
flexible, non-spherical protein, and is capable of forming dimers.
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1. Introduction
The cell cycle is driven by a family of protein kinases called
cyclin-dependent kinases (CDKs) [1]. The activity of CDK is
tightly regulated by an intricate system of protein-protein in-
teraction and phosphorylation [2]. Association with a cyclin
subunit is required for CDK activation. CDKs are activated
by phosphorylation of Thr161 and inhibited by phosphoryla-
tion of Thr14 and Tyr15. Furthermore, the activity of CDKs is
negatively regulated by binding to protein inhibitors of the
p21Cip1=WAF1 and p16INK4A family. In addition, the activities
of some CDKs are also regulated by binding to folding fac-
tors [3]. Many of these CDK regulators are known to be
regulated by degradation via the ubiquitin-proteasome system
[4].
Comparison of the composition of the proteins that asso-
ciate with cyclin-CDK complexes in normal and cancer cells
reveals proteins that are important for the deregulation of
cyclin-CDK in cancer cells [5]. Examples of these CDK regu-
lators are the CDK inhibitors p21Cip1=WAF1 and p16INK4A,
which are found in cyclin-CDK complexes in normal, but
not in many transformed cells. Lack of these CDK inhibitors
in transformed cells may contribute to the loss of normal
inhibition of CDK activity after DNA damage and increase
genomic instability. In normal human ¢broblasts, cyclin A-
Cdk2 exists in a quaternary complex that contains
p21Cip1=WAF1 and PCNA (proliferating cell nuclear antigen)
[6]. But in many transformed cells, p21Cip1=WAF1 and PCNA
disappear from the cyclin A-Cdk2 complexes, and instead a
substantial fraction of cyclin A-Cdk2 complexes are associ-
ated with a 19-kDa protein and a 45-kDa protein [5]. The
19-kDa and 45-kDa proteins were subsequently puri¢ed,
cloned, and were renamed Skp1 and Skp2, respectively [7].
The mRNA level of Skp2 is most abundant during the S
phase [7]. Furthermore, microinjection of anti-Skp2 antibod-
ies or Skp2 antisense oligonucleotides into normal human
¢broblasts or HeLa cells inhibits entry into S phase (but not
S phase progression) [7]. These data suggest that Skp2 is an
important regulator of the S phase. Interestingly, the level of
Skp2 is higher in transformed cells than in normal cells, which
may explain the increased abundance of Skp2 binding to cy-
clin A-Cdk2 in transformed cells. Consistent with this, the
SKP2 gene has been mapped to chromosome position 5p13,
the SKP1 gene to 7q11.2 [8], and close homolog or a pseudo-
gene of SKP1 (SKP1B) was mapped to 12p12 [8]. All three of
these loci are associated with karyotypic alterations, known
ampli¢cations, or suspected tumor suppressor genes. The in-
creased abundance of Skp2-containing cyclin A-Cdk2 com-
plex in tumor cells could imply a partial deregulation of entry
into S phase, and may contribute to the process of cellular
transformation. The Skp1 found in cyclin A-Cdk2 complexes
does not bind cyclin A-Cdk2 directly, but indirectly through
Skp2 [7,9]. Skp1 binds to Skp2 via a novel structural motif in
Skp2 called the F-box [9], which is found in a large number of
diverse proteins including cyclin F and Cdc4p.
Identi¢cation of Skp1 homologs from C. elegans, A. thali-
ana, and yeast indicates that Skp1 is evolutionarily highly
conserved and may play an important role in the cell [10].
This is reinforced by the ¢ndings that Skp1 is involved in
diverse functions, including roles in ubiquitin-dependent pro-
tein degradation of cell cycle control and glucose sensing pro-
teins, kinetochore function, and tumorigenesis.
Skp1 was identi¢ed as a subunit of CBF3, a multiprotein
complex that binds centromere DNA in vitro [10]. Skp1 there-
fore represents an intrinsic kinetochore protein conserved
throughout eukaryotic evolution, and may be directly in-
volved in linking kinetochore function with the cell cycle.
Skp1 was also identi¢ed as a suppressor of cdc4 mutants
and as a cyclin F-binding protein [9]. In S. cerevisiae, mutants
of cdc4 and cdc34 are phenotypically indistinguishable, and
the genes are critical for S phase progression [11]. Cdc4p,
acting in concert with Cdc34p and Cdc53p, is involved in
the ubiquitin-dependent degradation of multiple cell cycle reg-
ulators, including Cln2p, Cln3p, Far1p, and Sic1p [12^14].
Cyclin F was isolated as a suppressor of the G1/S de¢ciency
of a cdc4 mutant [15], suggesting cyclin F may also be in-
volved in the destruction of other cell cycle regulators. The
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fact that Skp1 is associated with cyclin F and Cdc4p suggests
that Skp1 may also be involved in the ubiquitin-dependent
destruction of cell cycle regulators. Indeed Skp1 was found
to be required for ubiquitin-mediated proteolysis of Cln2p,
Clb5p, and Sic1p [9]. Skp1p, Cdc4p, and Cdc53p assemble
into an ubiquitin ligase complex named SCFCdc4p, that can
reconstitute ubiquitination of phosphorylated Sic1p in the
presence of E1 enzyme, the E2 enzyme Cdc34p, and ubiquitin
[16^18]. Cdc53p is homologous to the cullins family of pro-
teins, which are involved in cell cycle exit in C. elegans [19]
and degradation of cell cycle regulators [19]. It is believed that
various SCF complexes exist in the cell, with Cdc53 (cullins)
and Skp1 associating with di¡erent F-box-containing proteins
[9,20,21]. Di¡erent cellular processes are regulated by SCF
complexes containing di¡erent F-box proteins: Cdc4p for
the degradation of Sic1p, Skp2 for the regulation of cyclin
A, Grr1p for degradation of G1 cyclin Cln2 and glucose in-
duction of HXT expression [21], and Met30p for methionine
biosynthesis [22]. The nature of the interactions between Skp1
and F-box proteins will shed light on the speci¢c degradation
as a regulatory mechanism. Towards this goal, here we de-
scribe the biochemical analysis of Skp1 and the investigation
of the interaction between Skp1 and Skp2.
2. Materials and methods
2.1. Constructs
Human Skp1 was ampli¢ed from a human cDNA library (from
peripheral lymphocytes transformed with EBV, a gift from K. Yama-
shita, Kanazawa University, Japan) by PCR with primers 5P-CACC-
ATGGCTTCAATTAAGTTGCA-3P (Skp1 FOR) and 5P-ACCTCG-
AGCTTCTCTTCACACCACTGGTT-3P ; the PCR product was cut
with NcoI-XhoI and put into pGEX-KG (Pharmacia, Uppsala, Swe-
den) (GST-Skp1 in pGEX-KG) and pET21d (Novagen, Madison, WI,
USA) (Skp1-H6 in pET21d). The second residue of Skp1 was changed
from a Pro to an Ala due to the subcloning. C-terminal truncation
mutants of Skp1 were constructed by PCR using 5P-GACCCAATG-
TGCCTGGATGCG-3P and 5P-TTGCTCGAGGAACTGGCTAAT-
CATCTC-3P (Cv41), 5P-GGCTCGAGCTAGTGGTGGGTGCAC-
CA-3P (Cv65), or 5P-ACCTCGAGCTAACCTTTGATGTCTA-3P
(Cv114); the PCR products were cut with NcoI-XhoI, and ligated
into pGEX-KG. N-terminal truncation mutants of Skp1 were con-
structed by PCR using 5P-CATCACCGAAACGCGCGAGGC-3P
and 5P-GGCCATGGATGATGAAGGAGATG-3P (Nv36), 5P-CCC-
CATGGATGACCCTCCTCCTCCTG-3P (Nv67), or 5P-CACCATG-
GGTTTGCTTGATGTTACAT-3P (Nv114); the PCR products were
cut with NcoI-XhoI, and ligated into pGEX-KG. The sequences of the
constructs were con¢rmed by double-stranded DNA sequencing. Hu-
man Skp2 clone (Skp2 in pBluescript SK3) was a gift from David
Beach (Cold Spring Harbor Laboratory) [7]. Skp1 in pACT2 was
constructed by PCR with primers Skp1 FOR and 5P-TTTCCATGGT-
CATCACCGAAACGCGCGAG-3P, cleaved with NcoI and ligated
into pACT2. To construct Skp2 in pAS2, Skp2 was ampli¢ed by
PCR from Skp2 in pBluescript SK3 with primers 5P-TTCCATGGA-
CGTATTTAAAACTCCCGGGC-3P and 5P-ATCTCGAGTAGACA-
ACTGGGCTTTTGCAGTGT-3P, cut with NcoI and XhoI, and li-
gated into pAS2. GST-Skp2 in pGEX-KG was constructed by
ligation of the same PCR fragment into NcoI and XhoI cut pGEX-
KG.
2.2. Expression and puri¢cation of recombinant proteins
Expression of GST-tagged and histidine-tagged proteins in bacteria
and puri¢cation with GSH-agarose and nickel-NTA agarose chroma-
tography, respectively, were as described [23]. Protein concentrations
were estimated by SDS-PAGE gel and Coomassie blue staining using
BSA as standard. Thrombin digestion of GST-fusion proteins and
inactivation of thrombin were as described [24]. Coupled transcrip-
tion-translation reactions in the presence of [35S]methionine in rabbit
reticulocyte lysate were performed according to the manufacturer’s
instructions (Promega, Madison, WI, USA).
2.3. Cell extracts
HeLa cells (human cervical carcinoma cells) were grown in Dulbec-
co’s modi¢ed Eagle’s medium (DMEM) supplemented with 10% (v/v)
calf serum in a humidi¢ed incubator at 37‡C, in 5% CO2. Cell-free
extracts were prepared as described [23]. The protein concentration of
cell lysates was measured with bicinchoninic acid protein assay system
(Pierce, Rockford, IL, USA) using BSA as a standard.
2.4. Circular dichroism spectroscopy
Equilibrium circular dichroism (CD) spectra were measured on a
Jasco J-720 spectropolarimeter, using a 0.1-mm path length quartz
cuvette at 20‡C. Samples were dissolved in bu¡er as speci¢ed, and
protein concentrations were determined by SDS-PAGE gel using BSA
as a standard. Secondary structure analysis was performed using the
Secondary Structure Estimation 38 program according to the manu-
facturer, using the reference CD spectra as described [25].
2.5. Nano-di¡erential scanning calorimetry
Calorimetry was performed using a Nano-Di¡erential Scanning
Calorimeter (NDSC) from Calorimetry Sciences Corporation (CSC).
Puri¢ed Skp1-H6 was dissolved in bu¡er A to a concentration of
approximately 0.5 mg/ml (estimated by SDS-PAGE gel using BSA
as a standard), and was degassed prior to the run. A heating scan
from 0‡C to 100‡C at a scan rate of 1‡C/s was used, followed by a
cooling scan from 100‡C to 0‡C at the same rate. Analysis was per-
formed using DSC analysis software from Microcal Corp., to calcu-
late the molar enthalpy and transition temperatures of the folding and
refolding reactions after subtraction of the baseline.
2.6. Gel ¢ltration chromatography
Samples (500 Wl) were applied onto a Superose 12 HR10/30 column
(Pharmacia) and subjected to FPLC chromatography with bu¡er A
(20 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM EDTA) with a £ow
rate of 0.4 ml/min. Fractions were collected at 1 fraction/min. The
fractions were lyophilized in a Speedvac and dissolved in 100 Wl of
SDS-sample bu¡er. Molecular size standards for the gel ¢ltration
column were: BSA (66 kDa), ovalbumin (43 kDa), carbonic anhy-
drase (28.8 kDa), RNaseA (13.7 kDa). Stokes’ radii of the standards
used were BSA (35.5 Aî ), ovalbumin (30.5 Aî ), carbonic anhydrase
(24.3 Aî ), RNaseA (16.4 Aî ). The Stokes’ radius of Skp1 was estimated
by applying the Porath and the Laurent and Killander relationships
[26]. Around 20 Wg of each standard protein or Skp1-H6 was loaded.
For cell extracts, 200 Wg of extracts were applied onto the column and
fractionated with the conditions as described above.
2.7. Glycerol gradient centrifugation
Isokinetic 5^25% glycerol gradients (in bu¡er A) were poured with
a two chamber gradient maker connected to a peristaltic pump (Gil-
son Miniplus3, 0.4 ml/min). Gradients (9 ml) were poured by displace-
ment method with a glass capillary tube at the bottom of the centri-
fugation tube (open ended PP ultracentrifuge tube of 11 ml capacity).
The glass tube was carefully removed vertically afterwards without
disturbing the gradient. About 50 Wg of each standard and Skp1-H6
in 200 Wl were loaded onto the gradients. Alternatively, standards and
150 Wl of 1 mg/ml cell extracts were loaded onto the gradients. Cen-
trifugation was performed in Sorvall Combiplus Ultracentrifuge with
a Sorvall TH641 swinging bucket rotor at 40 000 rpm for 23 h at 4‡C.
Fractions were collected at 0.4 ml/fraction from the bottom of the
tube using a ¢ne capillary tube. The fractions were TCA-precipitated,
and dissolved in 150 Wl SDS-sample bu¡er (for Skp1-H6) or 100 Wl
SDS-sample bu¡er (for cell extracts). The sedimentation coe⁄cient of
the sample protein was estimated by comparison with the standards
[27]. The sedimentation coe⁄cients of the standards used were: BSA
(4.31U10313 s), ovalbumin (3.55U10313 s), carbonic anhydrase
(3.23U10313 s), RNaseA (1.78U10313 s). From the sedimentation
data alone, the molecular weight can be approximated by:
s1
s2
 M1
M2
 2=3
where s is sedimentation coe⁄cient and M is molecular size in kDa
[27].
2.8. Combination of gel ¢ltration chromatography and glycerol gradient
centrifugation data
Calculation of true molecular size by combining the Stokes’ radius
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from gel ¢ltration chromatography, and the sedimentation coe⁄cient
from glycerol gradient centrifugation was performed as described [28].
2.9. Binding assays
Bacterially expressed GST-fusion proteins (V100 ng) were incu-
bated with rabbit reticulocyte lysate programmed to contain 35S-la-
beled proteins (V5 Wl) at 30‡C for 30 min. GST-fusion proteins were
then recovered with 15 Wl GSH-agarose in 250 Wl bead bu¡er (50 mM
Tris-Cl, pH 7.4, 5 mM NaF, 250 mM NaCl, 5 mM EDTA, 5 mM
EGTA, 0.1% Nonidet P-40, 2 Wg/ml aprotinin, 15 Wg/ml benzamidine,
1 Wg/ml leupeptin, 10 Wg/ml soybean trypsin inhibitor). After incuba-
tion at 4‡C with end-to-end rotation for 45 min, the beads were
washed ¢ve times with 250 Wl of bead bu¡er. The samples were
then dissolved in 30 Wl of SDS-sample bu¡er and the bound 35S-
labeled proteins were detected by SDS-PAGE followed by Phosphor-
Imager analysis (Molecular Dynamics).
2.10. Cross-linking of proteins
Puri¢ed proteins (5 Wl) were incubated with 2 Wl of 750 mM sodium
phosphate bu¡er (pH 7.0), 5 Wl of 0.004% glutaraldehyde, and 8 Wl of
water at 23‡C. At the indicated time points, 4-Wl samples were taken
and dissolved in 36 Wl of SDS-sample bu¡er. Part of the samples (10
Wl) was applied onto SDS-PAGE and stained with Coomassie blue
stain.
2.11. Yeast two-hybrid interactions
Yeast two-hybrid interaction assays were performed as described
[29]. Yeast strain Y190 was co-transformed with a combination of
Skp1 in pACT2, Skp2 in pAS2, and the corresponding vectors as
indicated. Colonies were grown on Leu-, Tyr-selection plates contain-
ing X-gal. Interacting clones produced a dark blue color and non-
interacting clones remained white in color.
2.12. Antibodies and immunological methods
Goat anti-Skp1 antibodies were raised against a peptide corre-
sponding to the C-terminal 20 amino acids of human Skp1 (sc-1568,
Santa Cruz Biotechnology). Goat anti-Skp2 antibodies were raised
against a peptide corresponding to the N-terminal 19 amino acids
of human Skp2 (sc-1567, Santa Cruz Biotechnology). Rabbit antibod-
ies against Cdk2 and E72 anti-cyclin A monoclonal antibody [23] were
as previously described. Immunoblots were performed as described
[30].
3. Results
3.1. Interaction between Skp1 and the F-box-containing
protein Skp2
Skp1 and Skp2 were isolated as interactors of cyclin A-
Cdk2 complexes from mammalian cells. Fig. 1 shows that
our recombinant Skp1 and Skp2 can also interact in a yeast
two-hybrid system. Reporter activity was detected when Skp1
and Skp2 were co-transformed, but not when Skp1 or Skp2
were transformed individually into yeasts. To see whether
Skp1 and Skp2 can also interact in vitro, 35S-labeled Skp2
translated in rabbit reticulocyte lysate was incubated with
GST-Skp1 or GST, and the proteins then recovered with
GSH agarose. Fig. 2B shows that Skp2 was retained by
GST-Skp1 but not by the GST control (lanes 1 and 2).
To have an idea of the region of Skp1 that is involved in
binding to Skp2, we constructed deletion mutants of GST-
Skp1 that were truncated from either the N-terminus or the
C-terminus. The deletion mutants are summarized schemati-
cally in Fig. 2A. Nv or Cv denoted deletions from the N-
terminus and C-terminus of Skp1, respectively, and the num-
bers indicate the amino acid residues in Skp1 that the mutants
were deleted to. These GST-Skp1 deletion mutants were ex-
pressed in bacteria, and their ability to bind rabbit reticulo-
cyte lysate translated Skp2 was compared. Fig. 2B shows that
the smallest deletion of Skp1 from the N-terminus (Nv36)
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Fig. 2. Binding of deletion mutants of Skp1 to Skp2. A: Summary
of GST-Skp1 deletion mutants. GST-Skp1 was deleted from the N-
terminus or the C-terminus as described in Section 2. Nv or Cv de-
noted deletions from the N-terminus and C-terminus, respectively,
and the numbers indicate the amino acid residues in Skp1 that the
mutants were deleted to (full length Skp1 contains 163 amino acid
residues). B: Binding of Skp2 to GST-Skp1 and deletion mutants.
Skp2 translated in reticulocyte lysate in the presence of
[35S]methionine (5 Wl) was incubated with 100 ng of GST (lane 1),
GST-Skp1 (lane 2); C-terminal deletion mutants of GST-Skp1:
Cv114 (lane 3), Cv65 (lane 4), Cv41 (lane 5); or N-terminal dele-
tion mutants of GST-Skp1: Nv36 (lane 6), Nv67 (lane 7), Nv114
(lane 8) at 23‡C for 30 min. The GST-fusion proteins were then re-
covered with GSH-agarose as described in Section 2. The samples
were dissolved in SDS-sample bu¡er and associated Skp2 was de-
tected by SDS-PAGE followed by analysis with a PhosphorImager.
The positions of the molecular size markers (in kDa) are shown on
the left. C: Binding of Skp1 to GST-Skp2. Skp1-H6 was translated
in a coupled transcription-translation rabbit reticulocyte lysate sys-
tem in the presence of [35S]methionine. The lysates were incubated
with bacterially expressed GST-Skp2 (lane 1) or GST (lane 2).
GST-Skp2 and bound proteins were then precipitated with GSH-
agarose, and the Skp1-H6 was detected by SDS-PAGE followed by
analysis with a PhosphorImager.
Fig. 1. Interaction between Skp1 and Skp2. Yeast cells were co-
transformed with Skp1 in pACT2 and Skp2 in pAS2 (lane 1), Skp1
in pACT2 and pAS2 vector (lane 2), or pACT2 vector and Skp2 in
pAS2 (lane 3). Colonies were put onto a selection plate containing
X-gal. Interacting clones produced a dark blue color and non-inter-
acting clones remained white in color (rendered to gray scale here).
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already disrupted most of its binding to Skp2 (15% of wild-
type GST-Skp1 from quantitation of the PhosphorImager).
Further deletions from the N-terminus (Nv67 and Nv114)
reduced the binding to Skp2 close to background level. The
ability of Skp1 to bind Skp2 could be tolerated slightly more
by deletion of Skp1 from the C-terminus; Cv114 and Cv65
still retained more than 20% binding to Skp2 in comparison to
wild-type GST-Skp1. Further deletion of Skp1 from the C-
terminus (Cv41) abolished all the binding to Skp2. Hence it is
likely that most of the Skp1 is required for binding to Skp2,
with the N-terminal region playing a slightly more prominent
part.
To eliminate the possibility that Skp1 was just a very
‘sticky’ protein that bound non-speci¢cally to any protein in
in vitro assays, we performed the inverse experiment by trans-
lating Skp1 in rabbit reticulocyte lysate in the presence of
[35S]methionine, and assaying whether the Skp1 could bind
to GST-Skp2. Fig. 2C shows that Skp1 translated in rabbit
reticulocyte lysate was recruited by GST-Skp2 fusion protein,
but not by GST alone. This indicates that Skp1 at least binds
speci¢cally to Skp2 and not to GST.
3.2. Expression and puri¢cation of recombinant Skp1
To further characterize the biochemical properties of Skp1,
human Skp1 was subcloned into vectors that expressed C-
terminal hexa-histidine-tagged Skp1 (Skp1-H6) and GST-fu-
sion Skp1 (GST-Skp1), respectively, in bacteria. Skp1-H6 and
GST-Skp1 were puri¢ed with nickel-NTA agarose chromatog-
raphy and GSH-agarose chromatography, respectively. Fig.
3A shows the purity of the puri¢ed recombinant proteins by
SDS-PAGE and Coomassie blue staining. The identity of the
GST-Skp1 and Skp1-H6 were con¢rmed by immunoblotting
with an antibody raised against the C-terminal peptide of
Skp1 (Fig. 3B, lanes 2 and 3). In comparison, GST alone
was not detected by the anti-Skp1 antibody (lane 1). In the
Skp1-H6 preparation, the two minor faster migrating bands
were unlikely to be degradation products of Skp1-H6 because
they were also recognized by the anti-C-terminal peptide anti-
bodies (Fig. 3B). These faster migrating bands are likely to be
oxidative forms of Skp1-H6 (J. Endicott and R.Y.C.P., un-
published data).
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Fig. 4. Circular dichroism spectroscopy and nano-di¡erential scan-
ning calorimetry analysis of Skp1. A: Puri¢ed Skp1-H6 and GST-
Skp1 (5 Wg/ml) were analyzed by circular dichroism as described in
Section 2. The percentages of the calculated K-helix, L-sheet, turn,
and random coil structures of the proteins are shown. B: Di¡erent
concentrations of puri¢ed Skp1-H6 (2.0, 2.5, 4.0, 5.0, 10.0, 20.0 Wg/
ml) were subjected to circular dichroism spectroscopy analysis. The
measurement of helical structure (CD 222 nm) is plotted against the
protein concentration. C: The thermal stability of Skp1-H6 was an-
alyzed by nano-di¡erential scanning calorimetry as described in Sec-
tion 2. The energy per mol was measured in one heating scan (0^
100‡C) (upper solid line) followed by one cooling scan (100^0‡C)
(lower dotted line).
Fig. 3. Expression and puri¢cation of recombinant Skp1. A: GST
(lane 1), GST-Skp1 (lane 2), and Skp1-H6 (lane 3) were expressed
in bacteria and puri¢ed as described in Section 2. The puri¢ed pro-
teins were applied onto SDS-PAGE and stained with Coomassie
blue. Molecular size markers were loaded in lane 4. B: Puri¢ed
GST (lane 1), GST-Skp1 (lane 2), and Skp1-H6 (lane 3) (V10 ng)
were applied onto SDS-PAGE and immunoblotted with antibodies
raised against the C-terminal 20 amino acids peptide of Skp1.
R.W.M. Ng et al./FEBS Letters 438 (1998) 183^189186
To see whether the recombinant Skp1 proteins have folded
into any secondary structure, puri¢ed Skp1-H6 and GST-
Skp1 were analyzed by circular dichroism spectroscopy. Fig.
4A shows the estimated percentage of secondary structures in
Skp1-H6 and GST-Skp1. From these rough estimations,
Skp1-H6 contains about 28% K-helix, 6% L-sheets, 26% turns,
and 40% random coils. More importantly, the percentage of
helical estimation in the Skp1-H6 did not change signi¢cantly
by varying the concentration of Skp1-H6 (Fig. 4B). These
results indicate that Skp1-H6 contained secondary structure,
and the overall secondary structure did not change signi¢-
cantly at di¡erent concentrations of the protein. The concen-
tration of recombinant Skp1 used for the rest of this study
was in the range of 1^5 Wg/ml.
To have an idea of the stability of Skp1-H6, nano-di¡er-
ential scanning calorimetry was used to analyze the endother-
mic and exothermic processes associated with puri¢ed Skp1-
H6. Fig. 4C shows that Skp1-H6 appeared to start to dena-
ture at a fairly low temperature (V25‡C), and peaked at
V40‡C. The apparent denaturation of Skp1-H6 was not com-
pleted in a narrow temperature range, suggesting that there
could be subdomains within Skp1-H6 that have di¡erent un-
folding temperatures, or both intermolecular and intramolec-
ular interactions existed for Skp1-H6. Interestingly, there was
a minor peak of unfolding at around 75‡C when heating was
applied to Skp1-H6. After the heating scan, the Skp1-H6
sample was cooled at the same rate as the previous heating
scan. The shape of the energy-temperature curve for cooling is
nearly a mirror image of the heating curve. This suggests that
most of the Skp1-H6 appeared to have refolded. However, the
cooling curve is slightly shifted to a higher temperature, and
the minor peak at V75‡C seen during denaturation was not
observed during renaturation. These data show that the puri-
¢ed Skp1-H6 proteins may be thermal stable, which is in
agreement with the observation that Skp1-H6 was not precipi-
tated by boiling (unpublished data).
3.3. The native molecular size of Skp1
Given the possibility that bacterially expressed Skp1-H6
may not be a monomer, we next investigated the size of
Skp1-H6 by size fractionation chromatography. Skp1-H6, to-
gether with several molecular size standards, was applied onto
gel ¢ltration chromatography; the fractions were analyzed by
SDS-PAGE and Coomassie blue staining (Fig. 5). Signi¢-
cantly, we found that Skp1-H6 migrated at a size much larger
than expected for a monomer (predicted size 20 kDa). The
major peak of Skp1-H6 (fractions 36^37) appeared to have a
size larger than carbonic anhydrase (28.8 kDa) and similar to
ovalbumin (43 kDa). Skp1-H6 behaved as a fairly uniform
population on gel ¢ltration chromatography, without any
Skp1-H6 migrating at the front of the column (suggesting
that there was little protein aggregation). However, a minor
peak of Skp1-H6 migrating at a slightly larger size (fraction
34) was reproducibly observed, which may represent Skp1-H6
dimers (see below). From these gel ¢ltration chromatography
data alone, Skp1-H6 seemed to have a size much larger (V43
kDa and V66 kDa, respectively, for the two populations)
than its predicted monomeric size.
To see whether Skp1-H6 were monomers or dimers, we
measured the native molecular size of Skp1-H6 by combining
the Stokes’ radius (from gel ¢ltration chromatography) and
the sedimentation coe⁄cient (from glycerol gradient centrifu-
gation) according to the method of Siegel and Monty [28].
The Stokes’ radius of Skp1-H6 was estimated by comparing
with the standards from the gel ¢ltration chromatography
(Fig. 5) and applying the Porath and the Laurent and Kil-
lander relationships [26]. We estimated the Stokes’ radius of
the major peak of Skp1-H6 to be V29.7 Aî . To measure the
sedimentation coe⁄cient of Skp1-H6, Skp1-H6 and standard
proteins were loaded onto 15^25% glycerol gradient and sub-
jected to centrifugation. Fractions were collected after centri-
fugation and analyzed by SDS-PAGE and Coomassie blue
staining. The fact that the standards were applied together
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Fig. 5. Gel ¢ltration chromatography of recombinant Skp1. A mixture of Skp1-H6 and molecular size marker proteins was fractionated by gel
¢ltration chromatography as described in Section 2. The standard proteins used were BSA (66 kDa), ovalbumin (43 kDa), carbonic anhydrase
(28.8 kDa), RNaseA (13.7 kDa). The fractions were lyophilized, dissolved in SDS-sample bu¡er, and loaded onto a 17.5% SDS-PAGE gel. The
proteins were visualized by Coomassie blue staining. The positions of the molecular size standards (in kDa) for the SDS-PAGE are shown on
the left.
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with Skp1-H6 onto the same gradients ensured that they
served as internal standards irrespective of the variation of
the gradient preparations (data not shown). The sedimenta-
tion coe⁄cient of Skp1-H6 was estimated to be 1.97U10313 s
( þ 0.02U10313 s). Unlike the gel ¢ltration results, Skp1-H6
did not behave as a larger protein than its predicted size by
gradient centrifugation. Using the sedimentation data alone,
Skp1-H6 has an estimated size of V17 kDa.
When the data from the gel ¢ltration chromatography and
glycerol gradient centrifugation were combined, we calculated
the size of Skp1-H6 to be about 24 þ 1 kDa. The minor pop-
ulation of Skp1-H6 with an apparent larger size on gel ¢ltra-
tion chromatography was estimated to have a size of approx-
imately 50 kDa (this is a rough approximation because the
minor peak was not consistently well resolved by gradient
centrifugation). These results indicate that Skp1-H6 was
mainly a monomer, and it migrated anomalously on gel ¢ltra-
tion chromatography. However, there is also a population
that is of larger size, possibly representing the dimeric form
of Skp1-H6.
Dimeric form of Skp1 was further demonstrated by cova-
lently cross-linking of puri¢ed Skp1-H6 by glutaraldehyde
(Fig. 6). Skp1-H6 was incubated with either bu¡er or the
cross-linking agent glutaraldehyde. The reactions were
stopped at di¡erent time points by mixing with SDS-sample
bu¡er; the samples were then analyzed with SDS-PAGE and
Coomassie blue staining. A portion of Skp1-H6 was seen to
migrate at approximately double the size of monomeric Skp1-
H6 after incubation with glutaraldehyde (lanes 4^7), but not
after incubation with bu¡er alone (lanes 2^3). This larger
peptide after cross-linking was also recognized by anti-Skp1
antibodies (data not shown).
3.4. Skp1 associates with Skp2 as well as other proteins in
mammalian cell extracts
To see whether the size of the endogenous Skp1 in cell
lysates was any di¡erent from that of recombinant Skp1, ex-
tracts from human cervical carcinoma HeLa cells were frac-
tionated by gel ¢ltration chromatography as before. The frac-
tions were applied onto SDS-PAGE, transferred to
membranes and immunoblotted with antibodies against
Skp1 (Fig. 7). In comparison to recombinant Skp1, the en-
dogenous Skp1 in the cell extracts was widely distributed on
gel ¢ltration chromatography. This re£ects the fact that Skp1
was associated with other proteins in the cell, including some
in very large complexes. When we immunoblotted the same
column fractions with antibodies against Skp2, Skp2 was
found to be restricted to a single major peak (and some in
very large complexes). Although some portion of Skp1 co-
migrated with Skp2 on gel ¢ltration chromatography, the ma-
jority of Skp1 did not, indicating that only a portion of Skp1
may be complexed to Skp2 in the cell.
4. Discussion
Skp1 is a small protein that binds to kinetochore compo-
nents, as well as to cullins and F-box proteins for the ubiq-
uitination-dependent degradation of other proteins. Under-
standing the biochemical properties of Skp1 is important for
understanding how Skp1 functions in these processes. Here we
describe the production of GST- and histidine-fusion proteins
of human Skp1 from bacteria. Circular dichroism spec-
troscopy of recombinant Skp1 revealed that it contains sec-
ondary structures, and the secondary structures were inde-
pendent of Skp1 concentration. Nano-di¡erential scanning
calorimetry revealed that Skp1 denatured at low temperature,
but apparently could refold when the temperature was low-
ered. The low denaturation temperature of Skp1 could re£ect
the ability to undergo large conformational changes after
binding to other proteins.
On gel ¢ltration chromatography, the main population of
Skp1-H6 co-migrated with the 43-kDa ovalbumin. But these
Skp1-H6 were likely to represent monomeric Skp1-H6 (pre-
dicted size 20 kDa), which we think migrated anomalously on
gel ¢ltration columns. A second peak of Skp1-H6 on gel ¢l-
tration columns was likely to represent dimers. Combination
of gel ¢ltration chromatography and gradient centrifugation
analysis indicated that the size of the main population of
Skp1-H6 is around 24 kDa, and that of the minor population
is around 50 kDa. The existence of Skp1 dimers was sup-
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Fig. 7. Endogenous Skp1 in mammalian cell extracts. HeLa cell ex-
tracts were subjected to gel ¢ltration chromatography as described
in Section 2. The fractions were lyophilized, dissolved in SDS-sam-
ple bu¡er, and loaded onto a 17.5% SDS-PAGE gel. Proteins were
transferred onto Immobilon membranes and immunoblotted with
antibodies against Skp1 and Skp2 as indicated. Immunoblottings for
cyclin A and Cdk2 are also shown for comparison.
Fig. 6. Cross-linking of Skp1. Puri¢ed Skp1-H6 (about 2 Wg per
lane) was incubated with bu¡er (lanes 2-3) or with bu¡er containing
glutaraldehyde (lanes 4^7). At the indicated time points, the reac-
tions were terminated by addition of SDS-sample bu¡er and ana-
lyzed with SDS-PAGE followed by Coomassie blue staining. Molec-
ular size markers are loaded in lane 1 (indicated in kDa on the
left). The positions of the monomeric Skp1-H6 are indicated on the
right and the position of the dimeric Skp1-H6 is indicated by the
asterisk.
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ported by the fact that after treatment of Skp1-H6 with a
cross-linking agent, some Skp1-H6 can be detected to migrate
at approximately double the size of Skp1-H6 on denatured
SDS-PAGE. All these biophysical data suggest that Skp1-
H6 could be a fairly £exible, non-spherical protein, and is
capable of forming dimers.
We found that Skp1 could interact with Skp2 in vitro using
bacterially expressed and rabbit reticulocyte expressed pro-
teins, and in vivo using the yeast two-hybrid system. Skp1
also binds to Skp2 in mammalian cell extracts [7]. But based
on the gel ¢ltration chromatography analysis of cell extracts
(Fig. 7), a substantial portion of Skp1 appeared to associate
with proteins other than Skp2 in mammalian cells. These pro-
teins probably include other F-box proteins like cyclin F, and
the E3 ubiquitin ligase component cullin, the kinetochore pro-
tein complex, as well as other yet unidenti¢ed partners of
Skp1. We are currently characterizing potential Skp1-interact-
ing clones identi¢ed by cDNA library screening using the
yeast two-hybrid system (unpublished data).
Deletion analysis of Skp1 suggests that most of Skp1 is
necessary for binding to Skp2, but the N-terminal region
seems to be more important than the C-terminal region. In-
teresting, cullin (CUL1) was reported to bind to the N-termi-
nal half of Skp1 [20]. It would also be interesting to inves-
tigate which part of Skp1 is involved in binding to the
kinetochore protein complex. We found that similar regions
in Skp1 were involved in binding to Skp2 and cyclin F (un-
published data). Skp1 is a relatively small protein, and it is
possible that it can tolerate only a limited amount of deletion
before the ability to bind other proteins is lost. Like all dele-
tion analyses, it is important to note that truncation of part of
Skp1 may have completely disrupted the whole structure of
the remaining protein. In comparison to Skp1, the region of
Skp2 that binds Skp1 is more well de¢ned, partly because
Skp2 is a larger protein than Skp1. The F-box region of
Skp2 is su⁄cient to bind to Skp1, and mutations of conserved
residues in the F-box in Cdc4p [18] and Skp2 (unpublished
data) abolished their binding to Skp1.
The structure of Skp1 would be very revealing for the
understanding of the functions of Skp1 in di¡erent biological
processes. As shown here, the yield and purity of bacterially
expressed Skp1-H6 after one column puri¢cation were su⁄-
ciently high for us to pursue further crystal structure analysis
(J. Endicott and R.Y.C.P., unpublished data). We showed
that Skp1-H6 contained secondary structures (by circular di-
chroism spectroscopy), and the majority of Skp1-H6 behaved
as a uniform population on gel ¢ltration chromatography.
The population of Skp1-H6 that dimerized and the small
population that was oxidized may present problems for struc-
tural studies. Furthermore, the low temperature of denatura-
tion of Skp1-H6 may also render the crystallization process
more demanding. We found that Skp1-H6 translated in rabbit
reticulocyte lysate was able to bind to bacterially expressed
GST-Skp2, suggesting the recombinant Skp1-H6 is functional
in terms of binding to Skp2. Based on the truncation analysis
described here, it is probably not useful to study the structure
of a truncated version of Skp1, because the binding to its
physiological partners is also compromised. Eventually, the
structures of Skp1 in a complex with F-box proteins and cull-
ins will provide more understanding on how these proteins
target substrates for ubiquitination.
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